JP2024019604A - Skin cleansing composition - Google Patents
Skin cleansing composition Download PDFInfo
- Publication number
- JP2024019604A JP2024019604A JP2023213338A JP2023213338A JP2024019604A JP 2024019604 A JP2024019604 A JP 2024019604A JP 2023213338 A JP2023213338 A JP 2023213338A JP 2023213338 A JP2023213338 A JP 2023213338A JP 2024019604 A JP2024019604 A JP 2024019604A
- Authority
- JP
- Japan
- Prior art keywords
- feeling
- acid
- skin
- cleansing composition
- skin cleansing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 150000001413 amino acids Chemical class 0.000 claims abstract description 36
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 26
- 150000002148 esters Chemical class 0.000 claims abstract description 24
- 239000000787 lecithin Substances 0.000 claims abstract description 24
- 235000010445 lecithin Nutrition 0.000 claims abstract description 24
- 229940067606 lecithin Drugs 0.000 claims abstract description 23
- 239000004094 surface-active agent Substances 0.000 claims abstract description 23
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940106189 ceramide Drugs 0.000 claims description 29
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 19
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 19
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 19
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 19
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 17
- 150000005215 alkyl ethers Chemical class 0.000 claims description 13
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical group OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 claims description 6
- 230000014759 maintenance of location Effects 0.000 abstract 2
- 230000003020 moisturizing effect Effects 0.000 description 39
- 229940024606 amino acid Drugs 0.000 description 34
- 235000001014 amino acid Nutrition 0.000 description 34
- -1 fatty acid salt Chemical class 0.000 description 28
- 239000003945 anionic surfactant Substances 0.000 description 19
- 239000007921 spray Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 238000005406 washing Methods 0.000 description 18
- 206010016322 Feeling abnormal Diseases 0.000 description 14
- 239000002280 amphoteric surfactant Substances 0.000 description 13
- 238000004140 cleaning Methods 0.000 description 13
- 150000001783 ceramides Chemical class 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 239000002585 base Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 206010040880 Skin irritation Diseases 0.000 description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- JJOJFIHJIRWASH-UHFFFAOYSA-N Eicosanedioic acid Natural products OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 229960005261 aspartic acid Drugs 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229940031020 bis-ethoxydiglycol succinate Drugs 0.000 description 4
- MGQKBAKCRHGMEI-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] butanedioate Chemical compound CCOCCOCCOC(=O)CCC(=O)OCCOCCOCC MGQKBAKCRHGMEI-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- IEXXLSKKBWIDAC-ZOWNYOTGSA-M sodium;(3s)-3-(dodecanoylamino)-4-hydroxy-4-oxobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC(O)=O IEXXLSKKBWIDAC-ZOWNYOTGSA-M 0.000 description 4
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 4
- VCRXMSMANOGRCM-UHFFFAOYSA-N 2-(dodecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CC(O)=O VCRXMSMANOGRCM-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- JNFDQAYPZCYWLD-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate Chemical compound CCOCCOCCOC(=O)C1CCC(C(=O)OCCOCCOCC)CC1 JNFDQAYPZCYWLD-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229940099417 ceramide 2 Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 150000002305 glucosylceramides Chemical class 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- 229940093475 2-ethoxyethanol Drugs 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- OXTNCQMOKLOUAM-UHFFFAOYSA-N 3-Oxoglutaric acid Chemical compound OC(=O)CC(=O)CC(O)=O OXTNCQMOKLOUAM-UHFFFAOYSA-N 0.000 description 2
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 2
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229940048864 ceramide 1 Drugs 0.000 description 2
- 229940044176 ceramide 3 Drugs 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- GBGUSZWBYGKEBA-VBYMIUBRSA-N (2R)-2-hydroxy-N-[(E,2S,3R,6R)-1,3,6-trihydroxyoctadec-4-en-2-yl]tetracosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO)[C@H](O)\C=C\[C@H](O)CCCCCCCCCCCC GBGUSZWBYGKEBA-VBYMIUBRSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- TUBPSFQENHCYBW-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OCCN(CCO)CCO TUBPSFQENHCYBW-HVDRVSQOSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- DABQDIXIAXPQFG-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]ethanesulfonic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O DABQDIXIAXPQFG-UHFFFAOYSA-N 0.000 description 1
- FAZHDESNRICLLX-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O FAZHDESNRICLLX-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- YHCCCMIWRBJYHG-UHFFFAOYSA-N 3-(2-ethylhexoxymethyl)heptane Chemical compound CCCCC(CC)COCC(CC)CCCC YHCCCMIWRBJYHG-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NBDYSLCMCUDINP-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)N(C)CCC(O)=O NBDYSLCMCUDINP-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 1
- WAYLDHLWVYQNSQ-KEFDUYNTSA-N N-2-hydroxylignoceroylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC WAYLDHLWVYQNSQ-KEFDUYNTSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- GCDXVKZXCQGDHC-BLCQCPAESA-N [30-oxo-30-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC GCDXVKZXCQGDHC-BLCQCPAESA-N 0.000 description 1
- ZGBFGAHZKZQSLG-UMCOJZBLSA-N [30-oxo-30-[[(e,2s,3r,6r)-1,3,6-trihydroxyoctadec-4-en-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCC[C@@H](O)\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC ZGBFGAHZKZQSLG-UMCOJZBLSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940095137 ceramide 6 ii Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004983 dialkoxyalkyl group Chemical group 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- PSHRANCNVXNITH-UHFFFAOYSA-N dimethylamino acetate Chemical compound CN(C)OC(C)=O PSHRANCNVXNITH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- WORCCYVLMMTGFR-UHFFFAOYSA-M loxoprofen sodium Chemical compound [Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 WORCCYVLMMTGFR-UHFFFAOYSA-M 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULMXYNZCSJBKOQ-UHFFFAOYSA-N n-(3-hexadecoxy-3-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOC(O)CCN(CCO)C(=O)CCCCCCCCCCCCCCC ULMXYNZCSJBKOQ-UHFFFAOYSA-N 0.000 description 1
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
- CTIQLGJVGNGFEW-UHFFFAOYSA-L naphthol yellow S Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C([O-])=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 CTIQLGJVGNGFEW-UHFFFAOYSA-L 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229950006098 orthocaine Drugs 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- NSHPEBWOVULKBI-UHFFFAOYSA-M sodium;1-dodecoxydodecane;acetate Chemical compound [Na+].CC([O-])=O.CCCCCCCCCCCCOCCCCCCCCCCCC NSHPEBWOVULKBI-UHFFFAOYSA-M 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000013042 solid detergent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940048912 triethanolamine cocoyl glutamate Drugs 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/04—Carboxylic acids or salts thereof
- C11D1/10—Amino carboxylic acids; Imino carboxylic acids; Fatty acid condensates thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/74—Carboxylates or sulfonates esters of polyoxyalkylene glycols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/32—Amides; Substituted amides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
本発明は、洗い上がりの皮膚における平滑感、保湿感、及び柔軟感が総合的に優れた皮膚洗浄料組成物に関する。 TECHNICAL FIELD The present invention relates to a skin cleansing composition that provides overall excellent smoothness, moisturizing, and softness on the skin after washing.
皮膚を洗浄し、肌を清潔に保つことを目的とした製品として、洗顔料、ボディソープ、シャンプー等の様々な皮膚洗浄料組成物が提供されている。皮膚洗浄料組成物には、泡立ちの良さ、洗浄力の良さに加えて、使用感の良さが求められている。 BACKGROUND ART Various skin cleansing compositions such as facial cleansers, body soaps, and shampoos are provided as products for cleaning the skin and keeping the skin clean. Skin cleansing compositions are required not only to have good foaming properties and cleansing power, but also to have a good feeling of use.
使用感の良さの1つとして、肌の平滑感(つるつる感)は洗いあがりの良さを感じさせる特性であり、特に重要視される。例えば、特許文献1には、脂肪酸せっけん、両性界面活性剤またはアルカノールアミド型非イオン性界面活性剤、木通(モクツウ)またはレンゲソウの抽出エキスを含有する洗浄剤組成物が、洗浄後の肌のはり感及び肌のつるつる感に優れることが記載されている。特許文献2には、脂肪酸塩と、アシルイセチオン酸塩と、融点30~100℃のロウ、炭化水素、及びグリセリドから選択される少なくとも1つである固体脂とを含む固形洗浄剤組成物が、すすぎ時のつるつる感に優れることが記載されている。特許文献3には、アニオン界面活性剤、アルキルエーテルカルボン酸又はその塩、2-エチルヘキシルグリセリルエーテル、及び水を含有する皮膚洗浄剤組成物が、洗浄後の肌のつるつる感に優れることが記載されている。 As one of the characteristics of good usability, the smoothness (smoothness) of the skin is a characteristic that gives a feeling of good cleansing, and is particularly important. For example, Patent Document 1 discloses that a cleaning composition containing a fatty acid soap, an amphoteric surfactant or an alkanolamide type nonionic surfactant, and an extract of Mokutsu or Astragalus leaves the skin after washing. It is described that it has excellent firmness and smooth skin feeling. Patent Document 2 discloses that a solid detergent composition containing a fatty acid salt, an acyl isethionate, and a solid fat that is at least one selected from waxes, hydrocarbons, and glycerides having a melting point of 30 to 100°C is used for rinsing. It is described that it has an excellent smooth feeling over time. Patent Document 3 describes that a skin cleansing composition containing an anionic surfactant, an alkyl ether carboxylic acid or its salt, 2-ethylhexylglyceryl ether, and water provides an excellent smooth feeling on the skin after washing. ing.
肌のつるつるとした平滑感を求める皮膚洗浄剤組成物は、さっぱりした洗いあがり感が得られる一方で、使用後の肌における保湿感や柔軟感は失われやすい。つまり、これまでの皮膚洗浄用組成物では、使用後の肌におけるつるつるとした平滑感を、しっとりとした保湿感及びふっくらとした柔軟感と並立できておらず、この点で、総合的な使用感に優れたものとはいえない。 Skin cleansing compositions that require a smooth and smooth feeling on the skin provide a refreshing feeling after washing, but the skin tends to lose its moisturizing and soft feeling after use. In other words, conventional skin cleansing compositions have not been able to provide a smooth, smooth feeling on the skin after use, as well as a moist, moisturizing feeling and a plump, supple feeling. It cannot be said that it has a good feel.
そこで本発明は、洗い上がりの皮膚における平滑感、保湿感、及び柔軟感が総合的に優れた皮膚洗浄料組成物を提供することを目的とする。 Accordingly, an object of the present invention is to provide a skin cleansing composition that has comprehensively excellent smoothness, moisturizing feeling, and softness feeling on the skin after washing.
本発明者は鋭意検討の結果、皮膚洗浄料組成物において、アミノ酸系界面活性剤とともに、両親媒性エステルとカチオン化ヒアルロン酸及び/又はその塩とを配合し、更に、セラミド類を配合することで、洗い上がりの皮膚におけるつるつるとした平滑感とともに、しっとりとした保湿感及びふっくらとした柔軟感も良好に発揮されることを見出した。本発明は、この知見に基づいてさらに検討を重ねることにより完成したものである。 As a result of extensive studies, the present inventor has found that, in a skin cleansing composition, an amphiphilic ester and a cationized hyaluronic acid and/or a salt thereof are blended together with an amino acid surfactant, and ceramides are further blended. It has been found that the skin after washing has a smooth and smooth feeling, as well as a moisturizing feeling and a plump and soft feeling. The present invention was completed through further studies based on this knowledge.
即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. (A)アミノ酸系界面活性剤、(B)両親媒性エステル、並びに(C)セラミド、擬似セラミド、及びグリコセラミドからなる群より選択されるセラミド類を含有する、皮膚洗浄料組成物。
項2. 前記(B)成分が、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステル、ジカルボン酸ジアルコキシアルキルエステル、及び(エイコサン二酸/テトラデカン二酸)ポリグリセリル-10よりなる群から選ばれる、項1に記載の皮膚洗浄料組成物。
項3. 前記ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルが、シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコールである、項2に記載の皮膚洗浄料組成物。
項4. 前記(C)成分がグリコセラミドである、請求項1~3のいずれかに記載の皮膚洗浄料組成物。
項5. さらに、(D)レシチン及び/又はリゾレシチンを含有する、項1~4のいずれかに記載の皮膚洗浄料組成物。
That is, the present invention provides the inventions of the following aspects.
Item 1. A skin cleansing composition comprising (A) an amino acid surfactant, (B) an amphipathic ester, and (C) a ceramide selected from the group consisting of ceramide, pseudoceramide, and glycoceramide.
Item 2. Item 1, wherein the component (B) is selected from the group consisting of dicarboxylic acid bis(polyoxyalkylene alkyl ether) ester, dicarboxylic acid dialkoxyalkyl ester, and polyglyceryl-10 (eicosandioic acid/tetradecanedioic acid). skin cleansing composition.
Item 3. Item 3. The skin cleansing composition according to Item 2, wherein the dicarboxylic acid bis(polyoxyalkylene alkyl ether) ester is cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol.
Item 4. The skin cleansing composition according to any one of claims 1 to 3, wherein the component (C) is a glycoceramide.
Item 5. Item 5. The skin cleansing composition according to any one of Items 1 to 4, further comprising (D) lecithin and/or lysolecithin.
本発明の皮膚洗浄料組成物によれば、洗い上がりの皮膚における平滑感、保湿感、及び柔軟感を総合的に発揮することができる。 According to the skin cleansing composition of the present invention, it is possible to comprehensively exhibit a smooth feeling, a moisturizing feeling, and a soft feeling on the skin after washing.
本発明の皮膚洗浄料組成物は、(A)アミノ酸系界面活性剤(以下、(A)成分とも記載する)、(B)両親媒性エステル(以下、(B)成分とも記載する)、並びに(C)セラミド、擬似セラミド、及びグリコセラミドからなる群より選択されるセラミド類(以下、(C)成分とも記載する)を含有することを特徴とする。以下、本発明の皮膚洗浄料組成物について詳述する。 The skin cleansing composition of the present invention comprises (A) an amino acid surfactant (hereinafter also referred to as component (A)), (B) an amphipathic ester (hereinafter also referred to as component (B)), and (C) It is characterized by containing a ceramide selected from the group consisting of ceramide, pseudoceramide, and glycoceramide (hereinafter also referred to as component (C)). Hereinafter, the skin cleansing composition of the present invention will be explained in detail.
(A)アミノ酸系界面活性剤
本発明の皮膚洗浄料組成物は、(A)成分としてアミノ酸系界面活性剤を含有する。アミノ酸系界面活性剤を用いることで、皮膚洗浄料組成物が優れた洗浄力を発揮しながらも皮膚刺激を低減することができる。また、(A)成分を(B)成分及び(C)成分と共存させることにより、洗い上がりの皮膚における保湿感及び/又は柔軟感を良好に得ることができる。
(A) Amino acid surfactant The skin cleansing composition of the present invention contains an amino acid surfactant as component (A). By using an amino acid surfactant, the skin cleansing composition can exhibit excellent cleaning power while reducing skin irritation. Furthermore, by coexisting component (A) with component (B) and component (C), it is possible to obtain a good moisturizing feeling and/or soft feeling on the skin after washing.
アミノ酸系界面活性剤としては、洗浄力、皮膚刺激低減性、保湿感及び/又は柔軟感を好ましく得る観点から、アミノ酸系アニオン性界面活性剤及びアミノ酸系両性界面活性剤が挙げられる。アミノ酸系界面活性剤としては、アミノ酸系アニオン性界面活性剤及びアミノ酸系両性界面活性剤のうちいずれか一方を使用してもよいし、両方を組み合わせて使用してもよい。これらのアミノ酸界面活性剤の中でも、平滑感及び保湿感をより好ましく得る観点から、アミノ酸系アニオン性界面活性剤が挙げられ、柔軟感を好ましく得る観点から、アミノ酸系両性界面活性剤が好ましく用いられる。 Examples of the amino acid-based surfactant include amino acid-based anionic surfactants and amino acid-based amphoteric surfactants from the viewpoint of obtaining favorable detergency, skin irritation reduction properties, moisturizing feeling, and/or soft feeling. As the amino acid surfactant, either an amino acid anionic surfactant or an amino acid amphoteric surfactant may be used, or both may be used in combination. Among these amino acid surfactants, amino acid-based anionic surfactants can be mentioned from the viewpoint of obtaining a more preferable smooth feeling and moisturizing feeling, and amino acid-based amphoteric surfactants are preferably used from the viewpoint of obtaining a preferable soft feeling. .
本発明に使用されるアミノ酸系アニオン性界面活性剤としては、カルボン酸型アミノ酸系アニオン性界面活性剤及びスルホン酸型アミノ酸系アニオン性界面活性剤が挙げられる。 Examples of the amino acid-based anionic surfactant used in the present invention include carboxylic acid-type amino acid-based anionic surfactants and sulfonic acid-type amino acid-based anionic surfactants.
カルボン酸型アミノ酸系アニオン性界面活性剤としては、オクタノイル基、デカノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ココイル基等の炭素数8~24の飽和又は不飽和のN-アシル基を有するN-アシルアミノ酸が挙げられる。カルボン酸型アミノ酸系アニオン性界面活性剤におけるN-アシルアミノ酸としては、N-アシルサルコシン、N-アシルアスパラギン酸、N-アシルグルタミン酸、N-アシル-N-メチル-β-アラニン等が挙げられる。より具体的なカルボン酸型アミノ酸系アニオン性界面活性剤としては、N-ラウロイルサルコシン、ココイルサルコシン、N-ラウロイルアスパラギン酸、ココイルアスパラギン酸、N-ラウロイルグルタミン酸、ココイルグルタミン酸、N-ラウロイル-N-メチル-β-アラニン、ココイルメチルアラニン等が挙げられる。 Examples of carboxylic acid type amino acid-based anionic surfactants include N-acyl groups having saturated or unsaturated N-acyl groups having 8 to 24 carbon atoms such as octanoyl group, decanoyl group, lauroyl group, myristoyl group, palmitoyl group, and cocoyl group. - Acyl amino acids. Examples of the N-acylamino acid in the carboxylic acid type amino acid-based anionic surfactant include N-acylsarcosine, N-acylaspartic acid, N-acylglutamic acid, N-acyl-N-methyl-β-alanine, and the like. More specific carboxylic acid type amino acid-based anionic surfactants include N-lauroyl sarcosine, cocoyl sarcosine, N-lauroyl aspartic acid, cocoyl aspartic acid, N-lauroyl glutamic acid, cocoyl glutamic acid, and N-lauroyl-N-methyl. -β-alanine, cocoylmethylalanine, etc.
スルホン酸型アミノ酸系アニオン性界面活性剤としては、オクタノイル基、デカノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ココイル基等の炭素数8~24の飽和又は不飽和のN-アシル基を有するN-アシル-N-メチルタウリンが挙げられる。より具体的なスルホン酸型アミノ酸系アニオン性界面活性剤としては、N-ミリストイル-N-メチルタウリン、N-ラウロイル-N-メチルタウリン、ココイルメチルタウリン等が挙げられる。 Examples of sulfonic acid type amino acid-based anionic surfactants include N-acyl groups having a saturated or unsaturated N-acyl group having 8 to 24 carbon atoms such as an octanoyl group, a decanoyl group, a lauroyl group, a myristoyl group, a palmitoyl group, and a cocoyl group. -acyl-N-methyltaurine. More specific sulfonic acid type amino acid-based anionic surfactants include N-myristoyl-N-methyltaurine, N-lauroyl-N-methyltaurine, cocoylmethyltaurine, and the like.
なお、これらのアミノ酸系アニオン性界面活性剤は、塩の形態であってもよく、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;トリエタノールアミン(TEA)塩;アンモニウム塩等の形態をとることができる。 Note that these amino acid-based anionic surfactants may be in the form of salts, such as alkali metal salts such as sodium salts and potassium salts; triethanolamine (TEA) salts; ammonium salts, etc. be able to.
これらのアミノ酸系アニオン性界面活性剤の中でも、洗浄力、皮膚刺激低減性、保湿感及び/又は柔軟感を好ましく得る観点から、好ましくはN-ラウロイルアスパラギン酸、
ココイルグルタミン酸、N-ラウロイル-N-メチル-β-アラニン、ココイルメチルアラニン、ココイルメチルタウリンが挙げられ、より好ましくは、N-ラウロイルアスパラ
ギン酸ナトリウム、ココイルグルタミン酸トリエタノールアミン、N-ラウロイル-N-メチル-β-アラニンナトリウム、ココイルメチルアラニンナトリウム、ココイルメチルタウリンナトリウムが挙げられる。洗浄力をより一層好ましく得る観点から、更に好ましくは、N-ラウロイルアスパラギン酸ナトリウム、ココイルグルタミン酸トリエタノール
アミン、N-ラウロイル-N-メチル-β-アラニンナトリウム、ココイルメチルアラニンナトリウムが挙げられる。保湿感をより一層好ましく得る観点から、更に好ましくはN-ラウロイルアスパラギン酸ナトリウムが挙げられる。
Among these amino acid-based anionic surfactants, N-lauroyl aspartic acid, N-lauroyl aspartic acid,
Cocoyl glutamic acid, N-lauroyl-N-methyl-β-alanine, cocoyl methylalanine, and cocoyl methyl taurine are mentioned, and more preferred are sodium N-lauroyl aspartate, cocoyl glutamate triethanolamine, and N-lauroyl-N-methyl. - Sodium β-alanine, sodium cocoylmethylalanine, and sodium cocoylmethyltaurate. From the viewpoint of obtaining better detergency, more preferred examples include sodium N-lauroyl aspartate, triethanolamine cocoylglutamate, sodium N-lauroyl-N-methyl-β-alanine, and sodium cocoylmethylalanine. From the viewpoint of obtaining a more favorable moisturizing feeling, sodium N-lauroyl aspartate is more preferably used.
アミノ酸系アニオン性界面活性剤としては、上述のカルボン酸型アミノ酸系アニオン性界面活性剤及びスルホン酸型アミノ酸系アニオン性界面活性剤の中から1種を単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 As the amino acid-based anionic surfactant, one type from the above-mentioned carboxylic acid-type amino acid-based anionic surfactants and sulfonic acid-type amino acid-based anionic surfactants may be used alone, or two types may be used. The above may be used in combination.
これらのアミノ酸系アニオン性界面活性剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These amino acid-based anionic surfactants may be used alone or in combination of two or more.
本発明に使用されるアミノ酸系両性界面活性剤としては、例えば、アミドベタイン型両性界面活性剤およびアルキルベタイン型両性界面活性剤が挙げられる。アミノ酸系両性界面活性剤としては、洗浄力、皮膚刺激低減性、保湿感及び/又は柔軟感をより一層好ましく得る観点から、好ましくはアミドベタイン型両性界面活性剤が挙げられる。 Examples of the amino acid-based amphoteric surfactants used in the present invention include amidobetaine-type amphoteric surfactants and alkylbetaine-type amphoteric surfactants. As the amino acid-based amphoteric surfactant, an amidobetaine-type amphoteric surfactant is preferably used from the viewpoint of achieving better detergency, skin irritation-reducing properties, moisturizing feeling, and/or softer feeling.
アミドベタイン型両性界面活性剤は、一般式R1CO-NH-(CH2)n-N+(CH3
)2CH2CO2
-(式中、R1CO-基は、オクタノイル基、デカノイル基、ラウロイル基
、ミリストイル基、パルミトイル基、ココイル基等の炭素数8~24の飽和又は不飽和のN-アシル基を表し、nは2~8の整数を表す。)で表される化合物であり、洗浄力、皮膚刺激低減性、保湿感及び/又は柔軟感を好ましく得る観点から、好ましくは、コカミドプロピルベタイン、ラウリル酸アミドプロピルベタイン等が挙げられ、より好ましくは、コカミドプロピルベタインが挙げられる。
Amidobetaine type amphoteric surfactants have the general formula R 1 CO-NH-(CH 2 ) n -N + (CH 3
) 2 CH 2 CO 2 - (wherein, R 1 CO- group is a saturated or unsaturated N- group having 8 to 24 carbon atoms such as octanoyl group, decanoyl group, lauroyl group, myristoyl group, palmitoyl group, cocoyl group, etc.) represents an acyl group, and n represents an integer of 2 to 8), and from the viewpoint of achieving favorable detergency, skin irritation reducing properties, moisturizing feeling, and/or soft feeling, cocamide is preferably used. Examples include propyl betaine, lauric acid amidopropyl betaine, and more preferably cocamidopropyl betaine.
アルキルベタイン型両性界面活性剤は、一般式R2-N+(CH3)2CH2CO2
-(式中
、R2基は、オクチル基、デシル基、ラウリル基、ミリスチル基、パルミチル基、ヤシ油
脂肪酸アルキル基等の炭素数8~24の飽和又は不飽和アルキル基を表す。)で表される化合物であり、洗浄力、皮膚刺激低減性、保湿感及び/又は柔軟感を好ましく得る観点から、好ましくは、ラウリルジメチル酢酸ベタイン、テトラデセルジメチルアミノ酢酸ベタイン等が挙げられる。
The alkyl betaine type amphoteric surfactant has the general formula R 2 -N + (CH 3 ) 2 CH 2 CO 2 - (wherein R 2 group is an octyl group, a decyl group, a lauryl group, a myristyl group, a palmityl group, It is a compound represented by a saturated or unsaturated alkyl group having 8 to 24 carbon atoms such as a coconut oil fatty acid alkyl group, and is a compound represented by the following formula, from the viewpoint that it can preferably have detergency, skin irritation reduction property, moisturizing feeling, and/or soft feeling. Among these, preferable examples include lauryl dimethyl acetate betaine and tetradecel dimethylamino acetate betaine.
これらのアミノ酸系両性界面活性剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These amino acid-based amphoteric surfactants may be used alone or in combination of two or more.
なお、後述するように、本発明の皮膚洗浄料組成物においては(A)成分以外の界面活性剤を含んでもよいが、(D)成分を配合する場合は、より一層向上した柔軟性を得る観点から、(A)成分以外の界面活性剤を含まないことが好ましい。 As described below, the skin cleansing composition of the present invention may contain a surfactant other than the component (A), but when the component (D) is included, further improved flexibility can be obtained. From this point of view, it is preferable that no surfactant other than component (A) be included.
本発明の皮膚洗浄料組成物における(A)成分の含有量は特に限定されず、付与すべき洗浄力等に応じて適宜決定すればよいが、例えば、0.025~20重量%、好ましくは0.025~12重量%が挙げられる。また、本発明の皮膚洗浄料組成物は、(A)成分が後述の(B)成分と共存していることにより、(A)成分の含有量が少なくても効果的に洗浄力を発揮することができる。このような観点から、皮膚刺激性をさらに低減させるために、(A)成分の含有量の上記範囲の上限としては、例えば10重量%以下、好ましくは6重量%以下、より好ましくは2重量%以下が挙げられる。また、より優れた洗浄力を得る観点からは、(A)成分の上記含有量の上記範囲の下限としては、好ましくは0.05重量%以上、より好ましくは0.1重量%以上、さらに好ましくは0.5重量%以上、一層好ましくは1重量%以上、特に好ましくは1.5重量%以上が挙げられる。また、後述するように、本発明の皮膚洗浄料組成物においては(A)成分以外の界面活性剤を含んでもよいが、(A)成分以外の界面活性剤を含む場合は、(A)成分と(A)成分以外の界面活性剤との含有量の合計が上記範囲内となるように調整されることが好ましい。 The content of component (A) in the skin cleansing composition of the present invention is not particularly limited and may be determined as appropriate depending on the cleaning power to be imparted, but is, for example, 0.025 to 20% by weight, preferably Examples include 0.025 to 12% by weight. In addition, the skin cleansing composition of the present invention effectively exhibits cleaning power even when the content of component (A) is small because component (A) coexists with component (B) described below. be able to. From this point of view, in order to further reduce skin irritation, the upper limit of the above range for the content of component (A) is, for example, 10% by weight or less, preferably 6% by weight or less, more preferably 2% by weight. The following may be mentioned. In addition, from the viewpoint of obtaining better detergency, the lower limit of the above range of the content of component (A) is preferably 0.05% by weight or more, more preferably 0.1% by weight or more, and even more preferably is 0.5% by weight or more, more preferably 1% by weight or more, particularly preferably 1.5% by weight or more. In addition, as described below, the skin cleansing composition of the present invention may contain surfactants other than component (A), but when containing surfactants other than component (A), component (A) It is preferable that the total content of surfactants other than component (A) is adjusted to be within the above range.
(B)両親媒性エステル
本発明の皮膚洗浄料組成物は、(B)成分として両親媒性エステルを含有する。(B)成分を(A)成分及び(C)成分と共存させることにより、洗い上がりの皮膚における保湿感及び柔軟感を良好に得ることができる。
(B) Amphipathic Ester The skin cleansing composition of the present invention contains an amphipathic ester as the (B) component. By allowing component (B) to coexist with component (A) and component (C), it is possible to obtain a good moisturizing feeling and soft feeling on the skin after washing.
また、(B)成分は単独で洗浄作用を示さないが、(A)成分と共存させることによって、皮膚洗浄料組成物の洗浄力を向上させることもできる。 In addition, although component (B) does not exhibit a cleansing effect by itself, by coexisting with component (A), the cleansing power of the skin cleansing composition can be improved.
本発明において、両親媒性エステルは、日本薬局方一般試験法に定められた方法による測定で、導電率70~110μs/mに調整されたイオン交換水に常温で2質量%以上溶解し、かつ、油剤であるイソノナン酸イソトリデシル(日清オイリオグループ社製、サラコス913)にも常温(25℃)で10質量%以上溶解するものであり、エステル系界面活性剤は除かれる。 In the present invention, the amphipathic ester dissolves at room temperature in an amount of 2% by mass or more in ion-exchanged water whose conductivity is adjusted to 70 to 110 μs/m as measured by the method specified in the Japanese Pharmacopoeia General Test Methods, and It also dissolves in the oil agent isotridecyl isononanoate (Sarakos 913, manufactured by Nisshin Oilio Group) at room temperature (25° C.) in an amount of 10% by mass or more, and ester surfactants are excluded.
両親媒性エステルとしては特に限定されないが、保湿感及び洗浄力をより良好に得る観点から、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステル、ジカルボン酸ジアルコキシアルキルエステル、及び(エイコサン二酸/テトラデカン二酸)ポリグリセリル-10よりなる群から選ばれるものであることが好ましい。両親媒性エステルとしては、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステル、ジカルボン酸ジアルコキシアルキルエステル、及び(エイコサン二酸/テトラデカン二酸)ポリグリセリル-10の中からいずれかを単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの両親媒性エステルの中でも、保湿感及び洗浄力をより良好に得る観点から、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルがより好ましい。 Amphiphilic esters are not particularly limited, but from the viewpoint of obtaining better moisturizing feeling and detergency, dicarboxylic acid bis(polyoxyalkylene alkyl ether) esters, dicarboxylic acid dialkoxyalkyl esters, and (eicosanedioic acid/tetradecane) It is preferably selected from the group consisting of polyglyceryl-10 (diacid). As the amphiphilic ester, one of dicarboxylic acid bis(polyoxyalkylene alkyl ether) ester, dicarboxylic acid dialkoxyalkyl ester, and polyglyceryl-10 (eicosandioic acid/tetradecanedioic acid) is used alone. Alternatively, two or more types may be used in combination. Among these amphiphilic esters, dicarboxylic acid bis(polyoxyalkylene alkyl ether) esters are more preferred from the viewpoint of obtaining better moisturizing feeling and detergency.
本発明に使用されるジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルは、ジカルボン酸とポリオキシアルキレンアルキルエーテルとのジエステル化合物である。ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルのジエステル化合物を構成するジカルボン酸の具体例としては、例えば、シュウ酸、マロン酸、コハク酸、酒石酸、リンゴ酸、グルタル酸、アジピン酸、ペメリン酸、スベリン酸、アゼライン酸、セバシン酸、アスパラギン酸、グルタミン酸、アセトンジカルボン酸、フタル酸、シクロヘキサン-1,4-ジカルボン酸などが挙げられる。また、ジエステル化合物を構成するポリオキシアルキレンアルキルエーテルとしては、例えば、ポリオキシエチレンモノアルキルエーテルなどが挙げられ、より具体的には、例えば、ジエチレングリコールモノエチルエーテル、トリエチレングリコールモノエチルエーテルなどが挙げられる。 The dicarboxylic acid bis(polyoxyalkylene alkyl ether) ester used in the present invention is a diester compound of dicarboxylic acid and polyoxyalkylene alkyl ether. Specific examples of dicarboxylic acids constituting the diester compound of dicarboxylic acid bis(polyoxyalkylene alkyl ether) ester include oxalic acid, malonic acid, succinic acid, tartaric acid, malic acid, glutaric acid, adipic acid, pemelic acid, Examples include suberic acid, azelaic acid, sebacic acid, aspartic acid, glutamic acid, acetone dicarboxylic acid, phthalic acid, and cyclohexane-1,4-dicarboxylic acid. Examples of the polyoxyalkylene alkyl ether constituting the diester compound include polyoxyethylene monoalkyl ether, and more specifically, diethylene glycol monoethyl ether, triethylene glycol monoethyl ether, etc. It will be done.
これらのジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルの中でも、保湿感及び洗浄力をより良好に得る観点から、好ましくは、シクロヘキサン-1,4-ジカルボン酸とジエチレングリコールモノエチルエーテルとのジエステル化合物、具体的には、INCI名(International Cosmetic Ingredient Dictionary and Handbook,第13版,第1巻,CTFA,
2010年,p.331):BIS-ETHOXYDIGLYCOL CYCLOHEX
ANE 1,4-DICARBOXYLATEで表記される、シクロへキサン-1,4-
ジカルボン酸ビスエトキシジグリコールと称される化合物、及びコハク酸とジエチレングリコールモノエチルエーテルとのジエステル化合物、具体的には、INCI名(International Cosmetic Ingredient Dictionary and Handbook,第13版,第1巻,CTFA,2010年,p.331-33
2):BIS-ETHOXYDIGLYCOL SUCCINATEで表記される、コハ
ク酸ビスエトキシジグリコールと称される化合物が挙げらる。
Among these dicarboxylic acid bis(polyoxyalkylene alkyl ether) esters, diester compounds of cyclohexane-1,4-dicarboxylic acid and diethylene glycol monoethyl ether are preferred from the viewpoint of obtaining better moisturizing feeling and detergency, Specifically, the INCI name (International Cosmetic Ingredient Dictionary and Handbook, 13th edition, Volume 1, CTFA,
2010, p. 331): BIS-ETHOXYDIGLYCOL CYCLOHEX
Cyclohexane-1,4-, written as ANE 1,4-DICARBOXYLATE
A compound called bisethoxydiglycol dicarboxylate and a diester compound of succinic acid and diethylene glycol monoethyl ether, specifically, INCI name (International Cosmetic Ingredient Dictionary and Handbook, 13th edition, Volume 1, CTFA, 2010, p.331-33
2): A compound called bisethoxydiglycol succinate, which is represented by BIS-ETHOXYDIGLYCOL SUCCINATE, is mentioned.
また、本発明において、前記シクロへキサン-1,4-ジカルボン酸ビスエトキシジグリコールの具体例としては、例えば、日本精化株式会社製の「Neosolue-Aqulio(商品名)」等が挙げられる。また、前記コハク酸ビスエトキシジグリコールの具体例としては、例えば、高級アルコール工業株式会社製の「ハイアクオスター DCS(商品名)」等が挙げられる。 Further, in the present invention, specific examples of the bisethoxydiglycol cyclohexane-1,4-dicarboxylate include "Neosolue-Aqulio (trade name)" manufactured by Nippon Fine Chemical Co., Ltd., and the like. Further, as a specific example of the bisethoxydiglycol succinate, for example, "Hyakuo Star DCS (trade name)" manufactured by Kyoku Alcohol Kogyo Co., Ltd. can be mentioned.
これらのジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These dicarboxylic acid bis(polyoxyalkylene alkyl ether) esters may be used alone or in combination of two or more.
本発明に使用されるジカルボン酸ジアルコキシアルキルエステルは、ジカルボン酸とアルコキシアルコールとのジエステル化合物である。ジカルボン酸ジアルコキシアルキルのジエステル化合物を構成するジカルボン酸の具体例としては、例えば、シュウ酸、マロン酸、コハク酸、酒石酸、リンゴ酸、グルタル酸、アジピン酸、ペメリン酸、スベリン酸、アゼライン酸、セバシン酸、アスパラギン酸、グルタミン酸、アセトンジカルボン酸、フタル酸、シクロヘキサン-1,4-ジカルボン酸などが挙げられる。また、ジエステル化合物を構成するアルコキシアルコールとしては、例えば、2-メトキシエタノール、2-エトキシエタノールなどが挙げられる。 The dicarboxylic acid dialkoxyalkyl ester used in the present invention is a diester compound of dicarboxylic acid and alkoxy alcohol. Specific examples of dicarboxylic acids constituting the diester compound of dialkoxyalkyl dicarboxylate include oxalic acid, malonic acid, succinic acid, tartaric acid, malic acid, glutaric acid, adipic acid, pemeric acid, suberic acid, azelaic acid, Examples include sebacic acid, aspartic acid, glutamic acid, acetone dicarboxylic acid, phthalic acid, and cyclohexane-1,4-dicarboxylic acid. Furthermore, examples of the alkoxy alcohol constituting the diester compound include 2-methoxyethanol and 2-ethoxyethanol.
これらのジカルボン酸ジアルコキシアルキルエステル中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくは、コハク酸と2-エトキシエタノールとのジエステル化合物、具体的には、コハク酸ジエトキシエチルが挙げられる。 Among these dicarboxylic acid dialkoxyalkyl esters, a diester compound of succinic acid and 2-ethoxyethanol, specifically diethoxyethyl succinate, is preferable from the viewpoint of obtaining better skin irritation reducing properties and detergency. can be mentioned.
これらのジカルボン酸ジアルコキシアルキルエステル、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These dicarboxylic acid dialkoxyalkyl esters may be used alone or in combination of two or more.
本発明に使用される(エイコサン二酸/テトラデカン二酸)ポリグリセリル-10としては、特に限定されないが、例えば、日本精化株式会社製の「Neosolue-Aqua(商品名)」、「Neosolue-AquaS(商品名)」等が挙げられる。 The polyglyceryl-10 (eicosanedioic acid/tetradecanedioic acid) used in the present invention is not particularly limited, but includes, for example, "Neosolue-Aqua (trade name)" and "Neosolue-AquaS (trade name)" manufactured by Nippon Fine Chemical Co., Ltd. Product name)" etc.
本発明の皮膚洗浄剤組成物における(B)成分の含有量としては特に限定されないが、例えば0.2重量%以上が挙げられる。保湿感及び洗浄力をより良好に得る観点から、(B)成分の含有量としては好ましくは0.4重量%以上が挙げられる。平滑感をより良好に得る観点から、(B)成分の含有量としてはより好ましくは0.5重量%以上が挙げられる。(B)成分の含有量の上記範囲の上限は特に限定されないが、皮膚洗浄料組成物の安定性等の観点から、例えば5重量%以下、好ましくは3重量%以下、より好ましくは2重量%以下、さらに好ましくは1重量%以下が挙げられる。 The content of component (B) in the skin cleansing composition of the present invention is not particularly limited, but may be, for example, 0.2% by weight or more. From the viewpoint of obtaining better moisturizing feeling and detergency, the content of component (B) is preferably 0.4% by weight or more. From the viewpoint of obtaining a smoother feel, the content of component (B) is more preferably 0.5% by weight or more. The upper limit of the above range of the content of component (B) is not particularly limited, but from the viewpoint of stability of the skin cleansing composition, for example, 5% by weight or less, preferably 3% by weight or less, more preferably 2% by weight. Below, more preferably 1% by weight or less is mentioned.
本発明の皮膚洗浄剤組成物において、(A)成分と(B)成分との比率は特に限定されず、上記の各含有量により定まるが、保湿感及び洗浄力をより良好に得る観点から、(A)成分1重量部に対して(B)成分が例えば0.01~100重量部、好ましくは0.01~10重量部、より好ましくは0.02~5重量部、さらに好ましくは0.03~1重量部、特に好ましくは0.03~0.5重量部が挙げられる。 In the skin cleansing composition of the present invention, the ratio of component (A) to component (B) is not particularly limited and is determined by each of the above contents, but from the viewpoint of obtaining better moisturizing feeling and cleansing power, For example, the amount of component (B) per 1 part by weight of component (A) is 0.01 to 100 parts by weight, preferably 0.01 to 10 parts by weight, more preferably 0.02 to 5 parts by weight, and still more preferably 0.01 to 100 parts by weight. 03 to 1 part by weight, particularly preferably 0.03 to 0.5 part by weight.
(C)セラミド類
本発明の皮膚洗浄料組成物は、(C)成分としてセラミド類を含有する。(C)成分を(A)成分及び(B)成分と組み合わせることにより、平滑感、保湿感及び柔軟感を総合的に向上させることができる。
(C) Ceramides The skin cleansing composition of the present invention contains ceramides as the (C) component. By combining component (C) with component (A) and component (B), it is possible to comprehensively improve the smooth feeling, moisturizing feeling, and soft feeling.
セラミド類とは、セラミド、擬似セラミド、及び/又はグリコセラミドをいう。本発明においては、(C)成分として、セラミド、擬似セラミド、及びグリコセラミドのうちいずれか一種を使用してもよいし、複数種を組み合わせて使用してもよい。 Ceramides refer to ceramide, pseudoceramide, and/or glycoceramide. In the present invention, as component (C), any one of ceramide, pseudoceramide, and glycoceramide may be used, or a combination of multiple types may be used.
セラミドはスフィンゴ脂質の一種であり、スフィンゴシンのアミノ基に長鎖脂肪酸がアミド結合した化合物群の総称として公知の成分である。セラミドは、スフィンゴシンの構造(N-アシル基の構造など)及び長鎖脂肪酸の構造の違いにより、セラミド1、セラミド2、セラミド3、セラミド4、セラミド5、セラミド6I、セラミド6II、セラミド7、セラミド8、セラミド9、セラミド10等が挙げられる。これらのセラミドは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらのセラミドの中でも、好ましくはセラミド1、セラミド2、セラミド3が挙げられる。 Ceramide is a type of sphingolipid, and is a component known as a general term for a group of compounds in which a long-chain fatty acid is bonded with an amide bond to the amino group of sphingosine. Ceramides are classified into ceramide 1, ceramide 2, ceramide 3, ceramide 4, ceramide 5, ceramide 6I, ceramide 6II, ceramide 7, and ceramide due to differences in the structure of sphingosine (such as the structure of N-acyl group) and the structure of long chain fatty acids. 8, Ceramide 9, Ceramide 10, etc. These ceramides may be used alone or in combination of two or more. Among these ceramides, ceramide 1, ceramide 2, and ceramide 3 are preferred.
本発明で使用されるセラミドの由来については、特に制限されず、セラミドの種類等に応じて適宜設定すればよく、例えば、動植物から抽出したもの、微生物醗酵法によって得られたもの、化学的に合成したもの等のいずれであってもよい。 The origin of the ceramide used in the present invention is not particularly limited and may be determined as appropriate depending on the type of ceramide. For example, it may be extracted from animals or plants, obtained by microbial fermentation, or chemically It may be any one that is synthesized.
擬似セラミドは、セラミドと構造及び性質が類似したセラミド類縁体であり、具体的には、下記一般式(I)で示される化合物、及び一般式(II)で示される化合物から選択される化合物が挙げられる。 Pseudoceramide is a ceramide analog similar in structure and properties to ceramide, and specifically, a compound selected from a compound represented by the following general formula (I) and a compound represented by general formula (II). Can be mentioned.
式(I)中、R11は炭素数10~26の炭化水素基を表し、R12は炭素数9~25の炭化水素基を表し、Xは-(CH2)n-を表し、nは2~6の整数を表す。炭化水素基としては、好ましくはアルキル基又はアルケニル基が挙げられる。式(I)に示される擬似セラミドの具体例としては、N-(ヘキサデシロキシヒドロキシプロピル)-N-ヒドロキシエチルヘキサデカナミドが挙げられる。 In formula (I), R 11 represents a hydrocarbon group having 10 to 26 carbon atoms, R 12 represents a hydrocarbon group having 9 to 25 carbon atoms, X represents -(CH 2 ) n -, and n is Represents an integer from 2 to 6. The hydrocarbon group preferably includes an alkyl group or an alkenyl group. A specific example of the pseudoceramide represented by formula (I) is N-(hexadecyloxyhydroxypropyl)-N-hydroxyethylhexadecanamide.
式(II)中、R21及びR22は同一又は異なっていてよい炭素数1~40のヒドロキシル化されていてもよい炭化水素基を表し、R23は炭素数1~6のアルキレン基又は単結合を表し、R24は水素原子、炭素数1~12のアルコキシ基又は2,3-ジヒドロキシプロピルオキシ基を表す。但し、R23が単結合であるときはR24は水素原子である。炭化水素基としては、好ましくはアルキル基又はアルケニル基が挙げられる。 In formula (II), R 21 and R 22 represent an optionally hydroxylated hydrocarbon group having 1 to 40 carbon atoms, which may be the same or different, and R 23 represents an alkylene group having 1 to 6 carbon atoms or a single represents a bond, and R 24 represents a hydrogen atom, an alkoxy group having 1 to 12 carbon atoms, or a 2,3-dihydroxypropyloxy group. However, when R 23 is a single bond, R 24 is a hydrogen atom. The hydrocarbon group preferably includes an alkyl group or an alkenyl group.
これらの擬似セラミドは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These pseudoceramides may be used alone or in combination of two or more.
グリコセラミドは、スフィンゴ糖脂質として公知の成分である。スフィンゴ糖脂質は、単糖又はオリゴ糖が結合したセラミドである。本発明で用いられるグリコセラミドとしては、好ましくは単糖が結合したセラミドが挙げられ、より好ましくはグルコシルセラミド(グルコースが結合したセラミド)及びガラクトシルセラミド(ガラクトースが結合したセラミド)が挙げられ、更に好ましくはグルコシルセラミドが挙げられる。 Glycoceramide is a component known as a glycosphingolipid. Glycosphingolipids are ceramides with monosaccharides or oligosaccharides attached. The glycoceramide used in the present invention preferably includes monosaccharide-bound ceramide, more preferably glucosylceramide (glucose-bound ceramide) and galactosylceramide (galactose-bound ceramide), and still more preferably Examples include glucosylceramide.
また、グリコセラミドとしては、植物(例えば、コメヌカ、コムギ、コーン、コンニャク等の穀類;タモギタケ、マイタケ等の茸類等)、動物(例えば、哺乳動物の乳、牛脳等)、微生物(例えば、Aspergillus属、Rhizopus属、Monuscus属、Penicillium属に属する麹菌等)に由来するグリコセラミドが挙げられる。 In addition, glycoceramides include plants (e.g., grains such as rice bran, wheat, corn, and konnyaku; mushrooms such as Tamogitake and Maitake), animals (e.g., mammalian milk, cow brain, etc.), and microorganisms (e.g., Examples include glycoceramides derived from koji molds belonging to the genus Aspergillus, Rhizopus, Monuscus, Penicillium, etc.).
本発明の皮膚洗浄剤組成物における(C)成分の含有量としては特に限定されないが、例えば0.005~0.3重量%が挙げられる。(C)成分の上記範囲の下限としては、平滑感、保湿感及び/又は柔軟感をより良好に得る観点から、好ましくは0.01重量%以上が挙げられる。また、(C)成分の上記範囲の上限としては、製剤安定性の観点から、好ましくは0.2重量%以下、より好ましくは0.15重量%以下が挙げられる。 The content of component (C) in the skin cleansing composition of the present invention is not particularly limited, but may be, for example, 0.005 to 0.3% by weight. The lower limit of the above range of component (C) is preferably 0.01% by weight or more from the viewpoint of better obtaining a smooth feeling, a moisturizing feeling and/or a soft feeling. Further, the upper limit of the above range of component (C) is preferably 0.2% by weight or less, more preferably 0.15% by weight or less from the viewpoint of formulation stability.
更に、(C)成分がグリコセラミドである場合、(C)成分の上記範囲の下限としては、平滑感、保湿感及び/又は柔軟感をより良好に得る観点から、より好ましくは0.05重量%以上が挙げられ、さらに好ましくは0.08重量%以上が挙げられる。 Furthermore, when the component (C) is a glycoceramide, the lower limit of the above range of the component (C) is more preferably 0.05 weight from the viewpoint of better obtaining a smooth feeling, a moisturizing feeling, and/or a soft feeling. % or more, more preferably 0.08% by weight or more.
本発明の皮膚洗浄剤組成物において、(A)成分と(C)成分との比率は特に限定されず、上記の各含有量により定まるが、保湿感及び/又は柔軟感とぬるつき抑制性とをより良好に得る観点から、(A)成分1重量部に対して(C)成分が例えば0.0005~0.1重量部、好ましくは0.001~0.01重量部が挙げられる。 In the skin cleansing composition of the present invention, the ratio of component (A) to component (C) is not particularly limited, and is determined by each of the above-mentioned contents, but it can be used to improve moisturizing feeling and/or softness feeling and sliminess suppressing property. From the viewpoint of obtaining better results, the amount of component (C) to 1 part by weight of component (A) is, for example, 0.0005 to 0.1 part by weight, preferably 0.001 to 0.01 part by weight.
(D)レシチン及び/又はリゾレシチン
本発明の皮膚洗浄料組成物は、(D)成分としてレシチン及び/又はリゾレシチンを含有していてもよい。(D)成分は、柔軟感を向上させる目的で、(A)成分、(B)成分及び(C)成分とともに共存させることができる。
(D) Lecithin and/or lysolecithin The skin cleansing composition of the present invention may contain lecithin and/or lysolecithin as component (D). Component (D) can be present together with component (A), component (B), and component (C) for the purpose of improving softness.
本発明においては、(D)成分として、レシチン及びリゾレシチンの中から、レシチンを用いてもよいし、リゾレシチンを用いてもよいし、レシチンとリゾレシチンとを組み合わせて用いてもよい。 In the present invention, as component (D), lecithin may be used from among lecithin and lysolecithin, lysolecithin may be used, or lecithin and lysolecithin may be used in combination.
レシチンは、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトールなどのリン脂質と、トリグリセリド、脂肪酸、植物油からの炭水化物などの成分との混合物であり、医薬品、医薬部外品、化粧品において公知の成分である。 Lecithin is a mixture of phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol, and components such as triglycerides, fatty acids, and carbohydrates from vegetable oils, and is a well-known component in pharmaceuticals, quasi-drugs, and cosmetics. be.
本発明に使用されるレシチンとしては、動植物由来の天然レシチン(例えば、大豆レシチン、卵黄レシチン等)そのものであってもよいし、天然レシチンの化学処理物であってもよいし、天然レシチンの精製物であってもよい。天然レシチンの化学処理物としては、水素添加処理により得られた水素添加レシチン(例えば、完全水素添加レシチンや部分水素添加レシチン)、水酸化処理により得られた水酸化レシチン等が挙げられる。天然レシチンの精製物としては、アセトン等の溶剤によりホスファチジルコリンの含有量を高めたレシチンが挙げられる。 The lecithin used in the present invention may be natural lecithin derived from animals or plants (e.g., soybean lecithin, egg yolk lecithin, etc.), a chemically processed product of natural lecithin, or a purified natural lecithin. It may be a thing. Examples of chemically treated natural lecithin include hydrogenated lecithin obtained by hydrogenation treatment (for example, fully hydrogenated lecithin and partially hydrogenated lecithin), hydroxylated lecithin obtained by hydroxylation treatment, and the like. Examples of purified natural lecithin include lecithin with increased phosphatidylcholine content using a solvent such as acetone.
本発明に使用されるリゾレシチンとしては、上記のレシチン(天然レシチン、天然レシチンの化学処理物、天然レシチンの精製物)のリゾ体が挙げられる。リゾレシチンは、レシチンをホスホリパーゼA2などの酵素による加水分解(溶解)でホスファチジルコリンの2位の脂肪酸が除去された構造を有する。 Examples of the lysolecithin used in the present invention include lyso forms of the above-mentioned lecithin (natural lecithin, chemically treated natural lecithin, purified natural lecithin). Lysolecithin has a structure in which the fatty acid at the 2-position of phosphatidylcholine is removed by hydrolyzing (dissolving) lecithin with an enzyme such as phospholipase A2.
これらのレシチン及び/又はリゾレシチンは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These lecithins and/or lysolecithins may be used alone or in combination of two or more.
本発明の皮膚洗浄剤組成物における(D)成分の含有量としては特に限定されないが、柔軟感をより良好に得る観点から、例えば0.005~3重量%、好ましくは0.01~1重量%、より好ましくは0.01~0.5重量%が挙げられる。 The content of component (D) in the skin cleansing composition of the present invention is not particularly limited, but from the viewpoint of obtaining better softness, for example, 0.005 to 3% by weight, preferably 0.01 to 1% by weight. %, more preferably 0.01 to 0.5% by weight.
本発明の皮膚洗浄剤組成物において、(A)成分と(D)成分との比率は特に限定されず、上記の各含有量により定まるが、保湿感及び/又は柔軟感をより良好に得る観点から、(A)成分1重量部に対して(D)成分が例えば0.002~0.3重量部、好ましくは0.004~0.25重量部が挙げられる。 In the skin cleansing composition of the present invention, the ratio of component (A) to component (D) is not particularly limited, and is determined by each of the above contents, but from the viewpoint of obtaining better moisturizing feeling and/or softer feeling. For example, 0.002 to 0.3 parts by weight, preferably 0.004 to 0.25 parts by weight of component (D) per 1 part by weight of component (A).
他の成分
本発明の皮膚洗浄剤組成物には、前記成分の他に、本発明の効果を損なわない範囲で、製剤化等に必要とされる他の基剤や添加剤が含まれていてもよい。このような添加剤については、薬学的に許容されることを限度として特に制限されないが、例えば、水、炭素数1~5の低級アルコール(エタノール、イソプロパノール等)、及び多価アルコール(エチレングリコール、1,3-ブチレングリコール(1,3-BG)、プロピレングリコール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、ポリプロピレングリコール、グリセリン等)等の水性基剤;カチオン性界面活性剤、アニオン性界面活性剤、両イオン性界面活性剤等の界面活性剤(上記(A)成分及び(D)成分以外);防腐剤(メチルパラベン、プロピルパラベン、安息香酸、安息香酸ナトリウム、ソルビン酸等)、着香剤(シトラール、1,8-シネオール、シトロネラール、ファルネソール等)、着色剤(タール色素(褐色201号、青色201号、黄色4号、黄色403号等)、カカオ色素、クロロフィル、酸化アルミニウム等)、粘稠剤(カルボキシビニルポリマー、ヒプロメロース、ポリビニルピロリドン、アルギン酸ナトリウム、エチルセルロース、カルボキシメチルセルロースナトリウム、キサンタンガム、カラギーナン等)、pH調整剤(リン酸、塩酸、クエン酸、クエン酸ナトリウム、コハク酸、酒石酸、水酸化ナトリウム、水酸化カリウム、トリエタノールアミン、トリイソプロパノールアミン等)、湿潤剤(dl-ピロリドンカルボン酸ナトリウム液、D-ソルビトール液、マクロゴール等)、安定化剤(ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、エデト酸ナトリウム、メタリン酸ナトリウム、L-アルギニン、L-アスパラギン酸、DL-アラニン、グリシン、エリソルビン酸ナトリウム、没食子酸プロピル、亜硫酸ナトリウム、二酸化硫黄、クロロゲン酸、カテキン、ローズマリー抽出物等)、酸化防止剤、紫外線吸収剤、キレート剤、粘着剤、緩衝剤、溶解補助剤、可溶化剤、保存剤等の添加剤が挙げられる。これらの基材や添加剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの基材や添加剤の含有量は、製剤形態等に応じて適宜設定することができる。
Other Components In addition to the above-mentioned components, the skin cleansing composition of the present invention may contain other bases and additives necessary for formulation, etc., to the extent that they do not impair the effects of the present invention. Good too. Such additives are not particularly limited as long as they are pharmaceutically acceptable, but examples include water, lower alcohols having 1 to 5 carbon atoms (ethanol, isopropanol, etc.), and polyhydric alcohols (ethylene glycol, Aqueous bases such as 1,3-butylene glycol (1,3-BG), propylene glycol, isoprene glycol, diethylene glycol, dipropylene glycol, polypropylene glycol, glycerin, etc.); cationic surfactants, anionic surfactants, Surfactants such as amphoteric surfactants (other than components (A) and (D) above); preservatives (methylparaben, propylparaben, benzoic acid, sodium benzoate, sorbic acid, etc.), flavoring agents (citral, etc.); , 1,8-cineole, citronellal, farnesol, etc.), colorants (tar pigments (Brown No. 201, Blue No. 201, Yellow No. 4, Yellow No. 403, etc.), cacao pigments, chlorophyll, aluminum oxide, etc.), thickening agents (carboxyvinyl polymer, hypromellose, polyvinylpyrrolidone, sodium alginate, ethylcellulose, sodium carboxymethylcellulose, xanthan gum, carrageenan, etc.), pH adjusters (phosphoric acid, hydrochloric acid, citric acid, sodium citrate, succinic acid, tartaric acid, sodium hydroxide, potassium hydroxide, triethanolamine, triisopropanolamine, etc.), wetting agents (sodium dl-pyrrolidonecarboxylate solution, D-sorbitol solution, macrogol, etc.), stabilizers (dibutylhydroxytoluene, butylhydroxyanisole, sodium edetate, etc.) , sodium metaphosphate, L-arginine, L-aspartic acid, DL-alanine, glycine, sodium erythorbate, propyl gallate, sodium sulfite, sulfur dioxide, chlorogenic acid, catechin, rosemary extract, etc.), antioxidants, Additives include ultraviolet absorbers, chelating agents, adhesives, buffers, solubilizers, solubilizers, preservatives, and the like. These base materials and additives may be used alone or in combination of two or more. The contents of these base materials and additives can be appropriately set depending on the formulation form and the like.
本発明の皮膚洗浄剤組成物には、前記成分の他に、本発明の効果を損なわない範囲で、必要に応じて他の薬理成分を含有していてもよい。このような薬理成分としては、例えば、ビタミン類(ビタミンA類、ビタミンB1類、ビタミンB2類、ビタミンB5類、ビタミンB6類、ビタミンB12類、ビタミンC類、ビタミンD類、ビタミンK類、ナイアシン類、葉酸、ビオチン、リコペン等)、抗ヒスタミン剤(ジフェンヒドラミン、塩酸ジフェンヒドラミン等)、局所麻酔剤(プロカイン、テトラカイン、ブピパカイン、メピパカイン、クロロプロカイン、プロパラカイン、メプリルカイン又はこれらの塩、オルソカイン、オキセサゼイン、オキシポリエントキシデカン、ロートエキス、ペルカミンパーゼ、テシットデシチン等)、抗炎症剤(インドメタシン、フェルビナク、ジクロフェナクナトリウム、ロキソプロフェンナトリウム等)、皮膚保護剤(コロジオン、ヒマシ油等)、血行促進成分(ノニル酸ワニリルアミド、ニコチン酸ベンジルエステル、カプサイシン、トウガラシエキス等)、清涼化剤(メントール、カンフル、ボルネオール、ハッカ水、ハッカ油等)、ムコ多糖類(コンドロイチン硫酸ナトリウム、グルコサミン等)等が挙げられる。これらの薬理成分は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの薬理成分を含有させる場合、その含有量については、使用する薬理成分の種類、期待する効果等に応じて適宜設定すればよい。 In addition to the above-mentioned components, the skin cleansing composition of the present invention may contain other pharmacological components as necessary, within a range that does not impair the effects of the present invention. Such pharmacological ingredients include, for example, vitamins (vitamins A, vitamin B1, vitamin B2, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin K, niacin). folic acid, biotin, lycopene, etc.), antihistamines (diphenhydramine, diphenhydramine hydrochloride, etc.), local anesthetics (procaine, tetracaine, bupipacaine, mepipacaine, chloroprocaine, proparacaine, meprilcaine or their salts, orthocaine, oxesazein, oxypolyenthoxy) decane, rotoextract, percaminpase, tesitdesitin, etc.), anti-inflammatory agents (indomethacin, felbinac, diclofenac sodium, loxoprofen sodium, etc.), skin protectants (collodion, castor oil, etc.), blood circulation promoting ingredients (nonylic acid vanillylamide, nicotinic acid benzyl ester) , capsaicin, chili pepper extract, etc.), cooling agents (menthol, camphor, borneol, peppermint water, peppermint oil, etc.), mucopolysaccharides (sodium chondroitin sulfate, glucosamine, etc.), and the like. These pharmacological ingredients may be used alone or in combination of two or more. When these pharmacological components are included, the content may be appropriately determined depending on the type of pharmacological component used, the expected effect, and the like.
形態
本発明の皮膚洗浄剤組成物の形態については特に制限されず、液状、クリーム状、ゲル状等が挙げられるが、好ましくは常温で液状である。また、本発明の皮膚洗浄剤組成物は、液状の皮膚洗浄剤組成物がコットンや不織布等のシート基材に含浸させられた形態であってもよい。
Form The form of the skin cleansing composition of the present invention is not particularly limited, and may be liquid, cream, gel, etc., but is preferably liquid at room temperature. Furthermore, the skin cleansing composition of the present invention may be in the form of a sheet base material such as cotton or nonwoven fabric impregnated with the liquid skin cleansing composition.
容器
本発明の皮膚洗浄剤組成物を収容する容器については、特に制限されず、形態や用途等に応じて適宜選択すればよいが、例えば、噴霧式容器、注下又は滴下式容器(特に洗浄瓶)、ポンプ式容器、チューブ式容器、包装袋、箱状容器等が挙げられる。特に、本発明の皮膚洗浄剤組成物が液状である場合、容器としては、噴霧式容器、注下又は滴下式容器(特に洗浄瓶)、ポンプ式容器、及びポンプフォーマー容器が挙げられる。また、本発明の皮膚洗浄剤組成物がシート基材に含浸させられた形態である場合は、容器としては、包装袋、箱状容器が挙げられる。
Container The container for storing the skin cleansing composition of the present invention is not particularly limited and may be appropriately selected depending on the form and use, but examples include a spray type container, a pouring or dripping type container (especially a cleaning container). bottles), pump-type containers, tube-type containers, packaging bags, box-shaped containers, etc. In particular, when the skin cleansing composition of the present invention is in liquid form, examples of the container include a spray container, a pouring or dripping container (especially a cleaning bottle), a pump container, and a pump former container. Further, when the skin cleansing composition of the present invention is in the form of a sheet base material impregnated, examples of the container include a packaging bag and a box-shaped container.
本発明においては、これらの容器の中でも、肌への塗布の手軽さ及び塗布時における手等による物理摩擦を回避する観点から、特に好ましくは噴霧式容器が挙げられる。噴霧式容器としては、非エアゾール式スプレー容器であるポンプ式スプレー容器、及び、エアゾール式スプレー容器が挙げられる。噴霧式容器の口径(ノズル内径)としては、例えば0.01~3mmφ、好ましくは0.1~1mmφが挙げられる。噴霧式容器がポンプ式スプレー容器である場合の1プッシュあたりの噴射量としては、例えば0.05~1.2g、好ましくは0.1~0.3gが挙げられる。 In the present invention, among these containers, spray type containers are particularly preferred from the viewpoint of ease of application to the skin and avoidance of physical friction caused by hands or the like during application. Examples of spray containers include pump-type spray containers, which are non-aerosol spray containers, and aerosol spray containers. The diameter of the spray container (inner diameter of the nozzle) is, for example, 0.01 to 3 mmφ, preferably 0.1 to 1 mmφ. When the spray container is a pump-type spray container, the spray amount per push is, for example, 0.05 to 1.2 g, preferably 0.1 to 0.3 g.
用途
本発明の皮膚洗浄剤組成物は、洗浄のために皮膚に適用するものであれば特に限定されない。本発明の皮膚洗浄剤組成物が洗い上がりの皮膚におけるつるつるとした平滑感、しっとりとした保湿感、及びふっくらとした柔軟感に優れているため、皮膚に適用された後に洗い流す使用態様、より具体的には、皮膚の油脂、汗などの体液や汚れ等を除去するために用いられる皮膚洗浄料、及び化粧を落とすために用いられるクレンジング等、特に好ましくは上記皮膚洗浄料としての用途において好適である。
Application The skin cleansing composition of the present invention is not particularly limited as long as it is applied to the skin for cleansing. Since the skin cleansing composition of the present invention has excellent smoothness, moisturizing feeling, and plump softness on the skin after washing, it can be used in a more specific manner in which it is applied to the skin and then washed off. Specifically, it is particularly suitable for use as a skin cleansing agent, such as a skin cleansing agent used to remove body fluids such as skin oils and sweat, and dirt, and a cleansing agent used to remove makeup. be.
本発明の皮膚洗浄剤組成物は、水で薄めて泡立てて皮膚に塗布してもよいし、水で薄めることなく、泡立てずにそのまま皮膚に塗布することで使用してもよい。水で薄めることなく、泡立てずにそのまま皮膚に塗布することで使用する場合、1回当たりの使用量としては、界面活性剤の濃度及び汚れの程度等にもよるが、例えば洗顔に用いる場合0.5~3g、好ましくは1~2gが挙げられる。 The skin cleansing composition of the present invention may be diluted with water and lathered before being applied to the skin, or it may be used by being directly applied to the skin without diluting with water or lathering. When used by applying directly to the skin without diluting with water or lathering, the amount used per time depends on the concentration of the surfactant and the degree of dirt, but for example, when used for face washing, 0. .5 to 3 g, preferably 1 to 2 g.
具体的な使用態様として、本発明の皮膚洗浄剤組成物が注下又は滴下式容器(特に洗浄瓶)、ポンプ式容器、チューブ式容器等に収容されている場合は、皮膚洗浄剤組成物を容器からいったん手に取り、手で洗浄対象部位に塗布することができる。また、本発明の皮膚洗浄剤組成物がシート基材に含浸させられている場合は、シート基材を手に取り、洗浄対象部位にあてがうことで塗布することができる。 As a specific usage mode, when the skin cleansing composition of the present invention is stored in a pouring or dripping type container (especially a cleaning bottle), a pump type container, a tube type container, etc., the skin cleansing composition of the present invention can be used. You can take it out of the container and apply it to the area to be cleaned by hand. Furthermore, when a sheet base material is impregnated with the skin cleansing composition of the present invention, it can be applied by picking up the sheet base material and applying it to the area to be cleaned.
特に好ましい使用態様として、噴霧式容器、注下又は滴下式容器(特に洗浄瓶)、好ましくは噴霧式容器に収容された皮膚洗浄剤組成物を、手に取ることなく、直接的に洗浄対象部位に塗布することができる。このように、皮膚洗浄剤組成物を直接的に洗浄対象部位に塗布する場合、洗浄対象部位の皮膚と手との間に生じる摩擦や、洗浄部位の皮膚と気泡と間に生じる摩擦といった物理的摩擦を一切与えることなく、液流の機械力を利用するだけで洗浄することが可能になる。本発明の皮膚洗浄剤組成物は、低刺激且つ洗浄力に優れた処方であるため、このように物理的摩擦を与えずに液流の機械力を利用して洗浄することで、洗浄時における肌への負担が顕著に軽減され極めて優しい洗浄方法が可能となる。なお、本発明の皮膚洗浄剤組成物は、前述のような肌に物理的摩擦を与えない洗浄方法に特に適しているが、皮膚洗浄剤組成物を洗浄対象部位に塗布した後に手等を用いてこすり洗いする使用方法を除外するものではない。 As a particularly preferred mode of use, the skin cleansing composition contained in a spray type container, pouring or dropping type container (especially a cleaning bottle), preferably a spray type container, can be directly applied to the area to be cleaned without taking it into the hand. can be applied to. In this way, when a skin cleansing composition is applied directly to the area to be cleaned, physical forces such as friction between the skin of the area to be cleaned and the hand and friction between the skin of the area to be cleaned and air bubbles are generated. It becomes possible to clean by simply using the mechanical force of the liquid flow without applying any friction. The skin cleansing composition of the present invention has a formulation that is low irritation and has excellent cleaning power, so by cleaning using the mechanical force of the liquid flow without applying physical friction, The burden on the skin is significantly reduced and an extremely gentle cleaning method becomes possible. The skin cleansing composition of the present invention is particularly suitable for the above-mentioned cleaning method that does not apply physical friction to the skin. This does not exclude methods of use such as scrubbing.
本発明の皮膚洗浄剤組成物の洗浄対象部位としては、あらゆる身体部位の洗浄が可能であるため特に制限されず、例えば、手、髪、頭皮、体、顔等が挙げられる。特に、本発明の皮膚洗浄剤組成物が洗い上がりの皮膚における平滑感、保湿感、及び柔軟感に優れているため、これらの使用感を特に感じやすい顔への使用において好適である。 The site to be cleaned with the skin cleansing composition of the present invention is not particularly limited since any body site can be cleaned, and examples thereof include hands, hair, scalp, body, face, and the like. In particular, the skin cleansing composition of the present invention has excellent smoothness, moisturizing feeling, and softness on the skin after washing, and is therefore suitable for use on the face, which is particularly sensitive to these feelings.
洗浄後、皮膚洗浄剤組成物は、水で洗い流すことができる。水で洗い流す場合は、通常の洗顔と同様に行えばよいが、肌への負担を軽減させる観点からは、手による摩擦を与えないように水流の機械力を利用して洗い流すことが好ましい。 After washing, the skin cleansing composition can be rinsed off with water. When rinsing off with water, it can be done in the same way as normal face washing, but from the perspective of reducing the burden on the skin, it is preferable to use the mechanical force of the water stream to avoid friction from your hands.
製造方法
本発明の皮膚洗浄剤組成物は、前述する(A)~(C)成分、及び必要に応じて配合される(D)成分、並びに必要に応じて配合される他の成分等を混合して、所定の形態に調製することによって製造される。
Manufacturing method The skin cleansing composition of the present invention is prepared by mixing the above-mentioned components (A) to (C), component (D) blended as necessary, and other components blended as necessary. It is manufactured by preparing it into a predetermined form.
以下に実施例を示して本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited thereto.
表1~2に示す組成の皮膚洗浄剤組成物を調製した。表1~2に示す各成分の詳細は以下の通りである。調製した皮膚洗浄剤組成物を以下の評価試験に供した。 Skin cleansing compositions having the compositions shown in Tables 1 and 2 were prepared. Details of each component shown in Tables 1 and 2 are as follows. The prepared skin cleansing composition was subjected to the following evaluation test.
(A)アミノ酸系界面活性剤
・ココイルメチルタウリンNa(日油株式会社製「ダイヤポンK-SF(商品名)」)
・コカミドプロピルベタイン(川研ファインケミカル株式会社製「ソフタゾリンCPB(商品名)」)
・ココイルグルタミン酸TEA(味の素株式会社製 「アミソフトCT-12S(商品名)」)
・ココイルメチルタウリンナトリウム(日光ケミカルズ株式会社製「NIKKOL CMT-30(商品名)」)
・N-ラウロイル-N-メチル-β-アラニンナトリウム(日油株式会社製「ソフティルトAS-L(商品名)」)
・N-ラウロイルアスパラギン酸ナトリウム(旭化成ファインケミカル株式会社製「アミノフォーマー FLDS-L(商品名)」)
・ココイルメチルアラニンナトリウム(川研ファインケミカル株式会社製「アラノンACE(商品名)」)
・コカミドプロピルベタイン(日光ケミカルズ製「NIKKOL AM-3130N(商品名)」)
(a)その他の界面活性剤
・ラウリル硫酸ナトリウム(花王株式会社製「エマール 0(商品名)」
・ラウリン酸ナトリウム(日油株式会社製「ノンサールLN-1(商品名)」
・コカミドDEA(川研ファインケミカル株式会社製「アミゾールCDE-G(商品名)」)
・ポリオキシエチレンラウリルエーテル酢酸ナトリウム(花王株式会社製「カオーアキポ
RLM-100NV(商品名)」)
・モノステアリン酸ポリオキシエチレンソルビタン(花王株式会社製 レオドールTW-S120V(商品名))
・グリセリンモノー2-エチルヘキシルエーテル液(SEPPIC社製「sensiva
SC 50 JP(商品名)」)
・PEG-60水添ヒマシ油(ポリオキシエチレン硬化ヒマシ油;日光ケミカルズ株式会社製 「NIKKOL HCO-60(商品名)」)
(B)両親媒性エステル
・シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール(日本精化株式会社製「Neosolue-Aqulio(商品名)」)
・コハク酸ビスエトキシジグリコール(高級アルコール工業株式会社製「ハイアクオスター DCS(商品名)」)
(C)セラミド類
・セラミド2(高砂香料工業株式会社製「Ceramide TIC-001(商品名)」)
・グルコシルセラミド(一丸ファルコス株式会社製「水溶性セラミドRC(商品名)」)(D)レシチン及び/又はリゾレシチン
・リゾレシチン(協和発酵バイオ株式会社製「リゾレシチン協和(商品名)」)
・レシチン(日清オイリオグループ株式会社製「ベイシス LP-20(商品名)」)
(A) Amino acid surfactant/cocoyl methyl taurine Na (“Diapon K-SF (product name)” manufactured by NOF Corporation)
・Cocamidopropyl betaine (“Softazoline CPB (trade name)” manufactured by Kawaken Fine Chemicals Co., Ltd.)
・Cocoyl glutamic acid TEA (“Amisoft CT-12S (product name)” manufactured by Ajinomoto Co., Inc.)
・Sodium cocoyl methyltaurate (“NIKKOL CMT-30 (product name)” manufactured by Nikko Chemicals Co., Ltd.)
・N-lauroyl-N-methyl-β-alanine sodium (“Softilt AS-L (product name)” manufactured by NOF Corporation)
・Sodium N-lauroyl aspartate (“Aminoformer FLDS-L (product name)” manufactured by Asahi Kasei Fine Chemicals Co., Ltd.)
・Sodium cocoyl methylalanine (“Alanone ACE (product name)” manufactured by Kawaken Fine Chemicals Co., Ltd.)
・Cocamidopropyl betaine (“NIKKOL AM-3130N (product name)” manufactured by Nikko Chemicals)
(a) Other surfactants/sodium lauryl sulfate (“EMAL 0 (product name)” manufactured by Kao Corporation)
・Sodium laurate (“Nonsal LN-1 (product name)” manufactured by NOF Corporation)
・Cocamide DEA (“Amizol CDE-G (product name)” manufactured by Kawaken Fine Chemicals Co., Ltd.)
・Polyoxyethylene lauryl ether sodium acetate (Kao Akipo RLM-100NV (product name) manufactured by Kao Corporation)
・Polyoxyethylene sorbitan monostearate (Rheodor TW-S120V (product name) manufactured by Kao Corporation)
・Glycerin mono 2-ethylhexyl ether solution (SEPPIC “sensiva”
SC 50 JP (product name)”)
・PEG-60 hydrogenated castor oil (polyoxyethylene hydrogenated castor oil; “NIKKOL HCO-60 (product name)” manufactured by Nikko Chemicals Co., Ltd.)
(B) Amphiphilic ester cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol (Neosolue-Aqulio (product name) manufactured by Nippon Fine Chemical Co., Ltd.)
・Bisethoxydiglycol succinate (“Hyakuo Star DCS (product name)” manufactured by Kyoku Alcohol Kogyo Co., Ltd.)
(C) Ceramides/Ceramide 2 (“Ceramide TIC-001 (product name)” manufactured by Takasago International Corporation)
・Glucosylceramide (“Water-soluble Ceramide RC (trade name)” manufactured by Ichimaru Falcos Co., Ltd.) (D) Lecithin and/or lysolecithin ・Lysolecithin (“Lysolecithin Kyowa (trade name)” manufactured by Kyowa Hakko Bio Co., Ltd.)
・Lecithin (“Basis LP-20 (product name)” manufactured by Nisshin Oilio Group Co., Ltd.)
<つるつる感(平滑感)評価>
調製した皮膚洗浄剤組成物について、化粧品評価専門パネラー10名が洗いあがり時のつるつる感の評価を行った。具体的には、表1の各皮膚洗浄剤組成物についてはポンプ式スプレー容器(竹本容器株式会社製「Z-155-C110(商品名)」(1プッシュあたりの噴射量は0.15g)に収容し、1.5gを顔に直接的に噴霧することで塗布した。5秒程度放置し、その後、水で洗い流した。また、表2の各皮膚洗浄剤組成物についてはポンプフォーマー容器に収容し、1.5gを顔に塗布した。5秒程度擦り洗いを行い、その後、水で洗い流した。洗い流し後、水を拭き取らずに、肌のつるつる感(平滑感)を以下の指標に基づいて評価した。
5点:つるつる感(平滑感)が十分ある
4点:つるつる感(平滑感)がある
3点:つるつる感(平滑感)がややある
2点:つるつる感(平滑感)があまりない
1点:つるつる感(平滑感)が全くない
<Smoothness (smoothness) evaluation>
The prepared skin cleansing composition was evaluated by 10 panelists specializing in cosmetic evaluation for smoothness after washing. Specifically, each of the skin cleansing compositions in Table 1 was used in a pump-type spray container ("Z-155-C110 (trade name)" manufactured by Takemoto Yoki Co., Ltd. (spray amount per push is 0.15 g). The skin cleanser compositions in Table 2 were applied by spraying 1.5 g directly onto the face.It was left for about 5 seconds and then washed off with water. 1.5g was applied to the face. It was rubbed for about 5 seconds, and then washed off with water. After washing off, without wiping off the water, the smoothness of the skin was measured using the following index: The evaluation was based on
5 points: Sufficient smoothness (smoothness) 4 points: Smoothness (smoothness) 3 points: Somewhat smoothness (smoothness) 2 points: Not much smoothness (smoothness) 1 point: No smooth feel at all
パネラー10名の獲得スコアを合計し、以下の分類によりぬるつき感抑制性の程度を評価した。結果を表1~4に示す。
◎:40点以上
○:31点以上40点未満
△:22点以上33点未満
×:22点未満
The scores obtained by the 10 panelists were totaled, and the degree of slimy feeling suppression was evaluated according to the following classification. The results are shown in Tables 1 to 4.
◎: 40 points or more
○: 31 points or more but less than 40 points
△: 22 points or more but less than 33 points
×: Less than 22 points
<しっとり感(保湿感)評価>
調製した皮膚洗浄剤組成物について、化粧品評価専門パネラー10名が洗いあがり時のしっとり感(保湿感)の評価を行った。具体的には、表1の各皮膚洗浄剤組成物についてはポンプ式スプレー容器(竹本容器株式会社製「Z-155-C110(商品名)」(1プッシュあたりの噴射量は0.15g)に収容し、1.5gを顔に直接的に噴霧することで塗布した。5秒程度放置し、その後、水で洗い流した。また、表2の各皮膚洗浄剤組成物についてはポンプフォーマー容器に収容し、1.5gを顔に塗布した。5秒程度擦り洗いを行い、その後、水で洗い流した。タオルで顔を抑えて水を吸い取った後、しっとり感(保湿感)を以下の指標に基づいて官能評価することで採点した。
5点:しっとり感(保湿感)が十分ある
4点:しっとり感(保湿感)がある
3点:しっとり感(保湿感)がややある
2点:しっとり感(保湿感)があまりない
1点:しっとり感(保湿感)が全くない
<Moist feeling (moisturizing feeling) evaluation>
The prepared skin cleansing composition was evaluated by 10 panelists specializing in cosmetic evaluation on the moist feeling (moisturizing feeling) after washing. Specifically, for each skin cleansing composition in Table 1, a pump-type spray container ("Z-155-C110 (trade name)" manufactured by Takemoto Yoki Co., Ltd. (spray amount per push is 0.15 g)) was used. The skin cleanser compositions in Table 2 were applied by spraying 1.5 g directly onto the face.It was left for about 5 seconds and then washed off with water. 1.5g was applied to the face. It was rubbed for about 5 seconds, and then washed off with water. After holding the face with a towel and absorbing the water, the moist feeling (moisturizing feeling) was evaluated using the following index. The score was determined by sensory evaluation based on the following criteria.
5 points: Enough moist feeling (moisturizing feeling) 4 points: Moist feeling (moisturizing feeling) 3 points: Slightly moist feeling (moisturizing feeling) 2 points: Not much moist feeling (moisturizing feeling) 1 point: No moist feeling (moisturizing feeling) at all
パネラー10名の獲得スコアを合計し、以下の分類によりしっとり感(保湿感)の程度を評価した。結果を表1~4に示す。
◎:40点以上
○:28点以上40点未満
△:25点以上28点未満
×:25点未満
The scores obtained by the 10 panelists were totaled, and the degree of moisturizing feeling (moisturizing feeling) was evaluated according to the following classification. The results are shown in Tables 1 to 4.
◎: 40 points or more
○: 28 points or more but less than 40 points
△: 25 points or more but less than 28 points
×: Less than 25 points
<ふっくら感(柔軟感)評価>
調製した皮膚洗浄剤組成物について、化粧品評価専門パネラー10名が洗いあがり時のふっくら感(柔軟感)の評価を行った。具体的には、表1の各皮膚洗浄剤組成物についてはポンプ式スプレー容器(竹本容器株式会社製「Z-155-C110(商品名)」(1プッシュあたりの噴射量は0.15g)に収容し、1.5gを顔に直接的に噴霧することで塗布した。5秒程度放置し、その後、水で洗い流した。また、表2の各皮膚洗浄剤組成物についてはポンプフォーマー容器に収容し、1.5gを顔に塗布した。5秒程度擦り洗いを行い、その後、水で洗い流した。タオルで顔を抑えて水を吸い取った後、ふっくら感(柔軟感)を以下の指標に基づいて官能評価することで採点した。
5点:ふっくら感(柔軟感)が十分ある
4点:ふっくら感(柔軟感)がある
3点:ふっくら感(柔軟感)がややある
2点:ふっくら感(柔軟感)があまりない
1点:ふっくら感(柔軟感)が全くない
<Evaluation of plumpness (softness)>
The prepared skin cleansing composition was evaluated by 10 panelists specializing in cosmetic evaluation for its plumpness (softness) after washing. Specifically, for each skin cleansing composition in Table 1, a pump-type spray container ("Z-155-C110 (trade name)" manufactured by Takemoto Yoki Co., Ltd. (spray amount per push is 0.15 g)) was used. The skin cleanser compositions in Table 2 were applied by spraying 1.5 g directly onto the face.It was left for about 5 seconds and then washed off with water. 1.5g was applied to the face. It was rubbed for about 5 seconds, and then washed off with water. After holding the face with a towel and absorbing the water, the feeling of plumpness (softness) was evaluated using the following index. The score was determined by sensory evaluation based on the following criteria.
5 points: There is a sufficient feeling of plumpness (softness) 4 points: There is a feeling of plumpness (feeling of flexibility) 3 points: There is a slight feeling of plumpness (feeling of flexibility) 2 points: There is not much of a feeling of plumpness (feeling of flexibility) 1 point: No feeling of plumpness (flexibility) at all
パネラー10名の獲得スコアを合計し、以下の分類によりぬるつき感抑制性の程度を評価した。結果を表1~4に示す。
◎:40点以上
○:34点以上40点未満
△:23点以上34点未満
×:23点未満
The scores obtained by the 10 panelists were totaled, and the degree of slimy feeling suppression was evaluated according to the following classification. The results are shown in Tables 1 to 4.
◎: 40 points or more
○: 34 points or more but less than 40 points
△: 23 points or more but less than 34 points
×: Less than 23 points
表1~4に示すとおり、(A)アミノ酸系界面活性剤、(B)両親媒性エステル、並びに(C)セラミド類を含有する皮膚洗浄料組成物(実施例1~17)は、洗い上がりの皮膚における平滑感、保湿感、及び柔軟感が総合的に優れていた。これに対し、例えば(A)成分を含まずに(a)成分(他の界面活性剤)を含む皮膚洗浄料組成物(比較例11~20)は、保湿感や柔軟感に劣っていた。また、(B)成分を含まない皮膚洗浄料組成物(比較例1、2、5、6、9、10)は、特に保湿感が劣っていた。さらに、(C)成分を含まない皮膚洗浄料組成物(比較例1~8)は、特に平滑感が劣っていた。 As shown in Tables 1 to 4, the skin cleansing compositions (Examples 1 to 17) containing (A) an amino acid surfactant, (B) an amphipathic ester, and (C) ceramides had a The smooth feeling, moisturizing feeling, and soft feeling on the skin were overall excellent. On the other hand, for example, skin cleansing compositions containing component (a) (another surfactant) but not component (A) (Comparative Examples 11 to 20) were inferior in moisturizing feeling and soft feeling. In addition, the skin cleansing compositions (Comparative Examples 1, 2, 5, 6, 9, and 10) that did not contain component (B) were particularly poor in moisturizing feeling. Furthermore, the skin cleansing compositions (Comparative Examples 1 to 8) that did not contain component (C) were particularly poor in smoothness.
Claims (4)
The skin cleansing composition according to any one of claims 1 to 3, further comprising (D) lecithin and/or lysolecithin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023213338A JP2024019604A (en) | 2019-06-26 | 2023-12-18 | Skin cleansing composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019118268A JP2021004206A (en) | 2019-06-26 | 2019-06-26 | Skin cleansing composition |
JP2023213338A JP2024019604A (en) | 2019-06-26 | 2023-12-18 | Skin cleansing composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019118268A Division JP2021004206A (en) | 2019-06-26 | 2019-06-26 | Skin cleansing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024019604A true JP2024019604A (en) | 2024-02-09 |
Family
ID=74061665
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019118268A Pending JP2021004206A (en) | 2019-06-26 | 2019-06-26 | Skin cleansing composition |
JP2023213338A Pending JP2024019604A (en) | 2019-06-26 | 2023-12-18 | Skin cleansing composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019118268A Pending JP2021004206A (en) | 2019-06-26 | 2019-06-26 | Skin cleansing composition |
Country Status (4)
Country | Link |
---|---|
JP (2) | JP2021004206A (en) |
CN (1) | CN112449599A (en) |
TW (1) | TW202100137A (en) |
WO (1) | WO2020262160A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113548977A (en) * | 2021-07-12 | 2021-10-26 | 广州乐信生物科技有限公司 | Process for producing N-methyl-beta-alanine derivative |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0248520A (en) * | 1988-08-10 | 1990-02-19 | Pola Chem Ind Inc | Cleaning agent |
JP4934254B2 (en) * | 2001-09-25 | 2012-05-16 | 株式会社バスクリン | Weakly acidic detergent composition |
JP2003321328A (en) * | 2002-04-25 | 2003-11-11 | Nicostar Co Ltd | Skin cleansing composition |
ES2339006T3 (en) * | 2002-07-12 | 2010-05-14 | JOHNSON & JOHNSON GMBH | PRODUCTS THAT INCLUDE A DRY APPLICATOR, A WATERPROOF PHASE AND A LIPID PHASE. |
JP2008044857A (en) * | 2006-08-11 | 2008-02-28 | Toyobo Co Ltd | Ameliorating agent for skin roughening |
JP6153285B2 (en) * | 2011-07-04 | 2017-06-28 | 株式会社マンダム | Moisturizing cosmetics |
JP6235844B2 (en) * | 2012-09-20 | 2017-11-22 | 花王株式会社 | Cleaning composition for skin or hair |
WO2018180009A1 (en) * | 2017-03-30 | 2018-10-04 | ビタミンC60バイオリサーチ株式会社 | Fullerene-containing cosmetic composition |
JP7141628B2 (en) * | 2017-05-11 | 2022-09-26 | 日本精化株式会社 | cosmetics |
-
2019
- 2019-06-26 JP JP2019118268A patent/JP2021004206A/en active Pending
-
2020
- 2020-06-10 TW TW109119382A patent/TW202100137A/en unknown
- 2020-06-17 CN CN202080003391.6A patent/CN112449599A/en active Pending
- 2020-06-17 WO PCT/JP2020/023790 patent/WO2020262160A1/en active Application Filing
-
2023
- 2023-12-18 JP JP2023213338A patent/JP2024019604A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN112449599A (en) | 2021-03-05 |
WO2020262160A1 (en) | 2020-12-30 |
JP2021004206A (en) | 2021-01-14 |
TW202100137A (en) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7471780B2 (en) | Skin cleansing spray | |
JP2024019604A (en) | Skin cleansing composition | |
JP7360826B2 (en) | Liquid composition for skin cleansing | |
TW202114619A (en) | Skin-cleansing spray | |
JP2023184664A (en) | Skin cleanser composition | |
JP2004217614A (en) | Cleansing composition | |
WO2020262154A1 (en) | Skin cleanser composition | |
JP2020002049A (en) | External composition | |
JP2018058785A (en) | Foam-promoting agent | |
WO2020262151A1 (en) | Skin cleanser composition | |
JP7344020B2 (en) | Liquid composition for skin cleansing | |
JP2020002050A (en) | Skin washing agent composition | |
WO2020262152A1 (en) | Spray agent for cleaning skin | |
WO2020262153A1 (en) | Liquid composition for skin cleansing | |
WO2020262155A1 (en) | Spray agent for skin cleansing | |
WO2020262156A1 (en) | Liquid composition for skin cleansing | |
WO2020262159A1 (en) | Composition for skin wiping | |
JP7364502B2 (en) | skin cleansing composition | |
WO2021124496A1 (en) | Spray preparation for skin cleaning | |
WO2021124495A1 (en) | Skin cleanser composition | |
WO2021124497A1 (en) | Liquid composition for skin cleansing | |
JP2024002795A (en) | Pore plug removal aid | |
JP2021042178A (en) | Skin cleanser composition | |
JP2022061049A (en) | Skin cleansing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240115 |